| Serial Number | 79246315 |
| Word Mark | T'SUMOYLE |
| Filing Date | Tuesday, September 18, 2018 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, November 12, 2019 |
| Registration Number | 5905766 |
| Registration Date | Tuesday, November 12, 2019 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 27, 2019 |
| Goods and Services | Pharmaceuticals for use in dermatology, for skin care, for the treatment of skin and skin relating conditions and disorders, for the treatment of damaged skin and tissue, for the treatment of sunburn, for the protection of the dermis and epidermis, for skin wounds; pharmaceuticals for skin care and for the treatment of skin and skin relating conditions and disorders based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; pharmaceutical drugs for use in dermatology, for skin care, for the treatment of skin and skin relating conditions and disorders, for the treatment of damaged skin and tissue, for the treatment of sunburn, for the protection of the dermis and epidermis, for skin wounds; pharmaceutical drugs for skin care and for the treatment of skin and skin relating conditions and disorders based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; pharmaceutical preparations for use in dermatology, for skin care, for the treatment of skin and skin relating conditions and disorders, for the treatment of damaged skin and tissue, for the treatment of sunburn, for the protection of the dermis and epidermis, for skin wounds; pharmaceutical preparations for skin care and for the treatment of skin and skin relating conditions and disorders based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; sun tanning preparations for pharmaceutical purposes, containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; sun tanning preparations for pharmaceutical purposes, not containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; medicated dermatological preparations; dermatological pharmaceutical substances; dermatological pharmaceutical products; medicinal creams for the protection of the skin; skin care creams for medical use; skin care preparations for medical use; medicated skin creams and lotions; medicated creams for application after exposure to the sun; pharmaceutical skin lotions; preparations for cleansing the skin for medical use; chemical and biological preparations, substances, reagents and compounds for use in dermatology, for skin care, for the treatment of skin and skin relating conditions and disorders, for the treatment of damaged skin and tissue, for the treatment of sunburn, for the protection of the dermis and epidermis, for skin wounds, all used for the delivery and storage of pharmaceuticals containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide |
| Goods and Services | Non-medicated skin care preparations; cosmetic preparations for skin care; cosmetic preparations for skin care, based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; cosmetic oils; cosmetic skin creams; skin care creams, lotions and oils for cosmetic purposes; wrinkle removing skin care preparations; cosmetic sunscreen preparations; waterproof sunscreen; sunscreen preparations; sunscreen creams and lotions; cosmetics for protecting the skin from sunburn; sunblock lotions; cosmetic sun barriers; sun creams; cosmetic preparations for protecting the skin from the sun's rays; sun care lotions; cosmetic compounds for skin care after exposure to the sun's rays; after-sun milks, creams, lotions and moisturizers; sun skin bronzers; sun-tanning preparations; cosmetics for tanning the skin including preparations for tanning without sunlight, containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; cosmetics for tanning the skin including preparations for tanning without sunlight, not containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; cosmetic self-tanning preparations; self -tanning creams and lotions for cosmetic purposes; suntan creams, lotions, oils and gels; non-medicated skin rejuvenation preparations, namely, creams, lotions, moisturizers, gels, balms, serums, oils, toners, cleaners and peels; non-medicated skin rejuvenation products, namely, creams, lotions, moisturizers, gels, balms, serums, oils, toners, cleaners and peels with and without analogues of alpha-melanocyte stimulating hormone (alpha-MSH); non-medicated antiaging skincare preparations; antiaging creams, lotions, moisturizers, gels, balms and serums; skin cleansing creams, lotions, milks, foams, gels and masks for cosmetic purposes |
| Translation of Words in Mark | The wording "T'SUMOYLE" has no meaning in a foreign language. |
| International Class | 003 - Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices. |
| US Class Codes | 001, 004, 006, 050, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, November 30, 2018 |
| Primary Code | 003 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, November 30, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Clinuvel (UK) Ltd |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | London EC1M 7AD GB |
| Party Name | Clinuvel (UK) Ltd |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | London EC1M 7AD GB |
| Party Name | Clinuvel (UK) Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | London EC1M 7AD GB |
| Event Date | Event Description |
| Thursday, November 29, 2018 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, November 30, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, December 4, 2018 | APPLICATION FILING RECEIPT MAILED |
| Friday, December 28, 2018 | ASSIGNED TO EXAMINER |
| Friday, January 4, 2019 | NON-FINAL ACTION WRITTEN |
| Saturday, January 5, 2019 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, January 17, 2019 | REFUSAL PROCESSED BY MPU |
| Thursday, January 17, 2019 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, February 2, 2019 | REFUSAL PROCESSED BY IB |
| Thursday, July 11, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, July 16, 2019 | ASSIGNED TO LIE |
| Saturday, July 20, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, July 20, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, July 20, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 7, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, August 7, 2019 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, August 7, 2019 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Friday, August 23, 2019 | NOTIFICATION PROCESSED BY IB |
| Tuesday, August 27, 2019 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 27, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 12, 2019 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, February 12, 2020 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Friday, March 6, 2020 | FINAL DISPOSITION PROCESSED |
| Friday, March 6, 2020 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, March 27, 2020 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Tuesday, November 12, 2024 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |